Validation of Portable Monitoring Device for Diagnosing Sleep Apnea
NCT ID: NCT00628511
Last Updated: 2016-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
175 participants
OBSERVATIONAL
2007-01-31
2008-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of a Portable Sleep Device in Patients With Co-existing Medical Illnesses
NCT03930316
Evaluation of New Diagnostic and Treatment Algorithm for Obstructive Sleep Apnea
NCT00425659
Novel Device for Screening Patients With Symptoms of OSA
NCT03157440
Portable System for Non-intrusive Monitoring of Sleep
NCT06029881
Non-Invasive Measurement of Respiratory Effort
NCT00528749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Portable monitoring device is applied simultaneously with PSG to compare it's accuracy and validity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
observation
ARES (Apnea Risk Evaluation System)
application of portable monitoring device with PSG
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ARES (Apnea Risk Evaluation System)
application of portable monitoring device with PSG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The Hospital Authority
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
To K Wang, MBCHB
Role: PRINCIPAL_INVESTIGATOR
Chinese University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Chinese Univerisity of Hong Kong
Hong Kong, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6902256
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.